These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17888084)

  • 1. Bilateral iris cyst secondary to topical latanoprost.
    Pruthi S; Kashani S; Ruben S
    Acta Ophthalmol; 2008 Mar; 86(2):233-4. PubMed ID: 17888084
    [No Abstract]   [Full Text] [Related]  

  • 2. Iris cyst associated with topical administration of latanoprost.
    Krohn J; Hove VK
    Am J Ophthalmol; 1999 Jan; 127(1):91-3. PubMed ID: 9933009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iris cyst secondary to latanoprost mimicking iris melanoma.
    Sodhi PK
    Am J Ophthalmol; 2003 Oct; 136(4):780; author reply 780-1. PubMed ID: 14516849
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurring iris pigment epithelial cyst induced by topical prostaglandin F2 alpha analogues.
    Krohn J; Hove VK
    Arch Ophthalmol; 2008 Jun; 126(6):867-8. PubMed ID: 18541857
    [No Abstract]   [Full Text] [Related]  

  • 5. Iris cyst secondary to latanoprost mimicking iris melanoma.
    Browning DJ; Perkins SL; Lark KK
    Am J Ophthalmol; 2003 Mar; 135(3):419-21. PubMed ID: 12614778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iris pigment epithelial cyst induced by topical administration of latanoprost.
    Lai IC; Kuo MT; Teng LM
    Br J Ophthalmol; 2003 Mar; 87(3):366. PubMed ID: 12598462
    [No Abstract]   [Full Text] [Related]  

  • 7. The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change.
    Grierson I; Lee WR; Albert DM
    Arch Ophthalmol; 1999 Mar; 117(3):394-6. PubMed ID: 10088822
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence of early change in iris color with latanoprost use.
    Pappas RM; Pusin S; Higginbotham EJ
    Arch Ophthalmol; 1998 Aug; 116(8):1115-6. PubMed ID: 9715697
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased iris pigment in a child due to latanoprost.
    Brown SM
    Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807
    [No Abstract]   [Full Text] [Related]  

  • 10. Histology and fine structure of the iris and outflow system following latanoprost therapy.
    Grierson I; Pfeiffer N; Cracknell KP; Appleton P
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S176-84. PubMed ID: 12204715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes.
    Chou SY; Chou CK; Kuang TM; Hsu WM
    Eye (Lond); 2005 Jul; 19(7):784-7. PubMed ID: 15359238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of irises with a latanoprost-induced change in iris color.
    Arranz-Marquez E; Teus MA; Saornil MA; Mendez MC; Gil R
    Am J Ophthalmol; 2004 Oct; 138(4):625-30. PubMed ID: 15488791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin-induced iridial pigmentation in primates.
    Selén G; Stjernschantz J; Resul B
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S125-8. PubMed ID: 9154288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric effects of long-term exposure to latanoprost.
    Cracknell KP; Grierson I; Hogg P
    Ophthalmology; 2007 May; 114(5):938-48. PubMed ID: 17292473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iris morphology.
    Teus MA; Arranz-Marquez E
    Ophthalmology; 2008 Feb; 115(2):418-9; author reply 419-20. PubMed ID: 18243921
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.
    Albert DM; Gangnon RE; Grossniklaus HE; Green WR; Darjatmoko S; Kulkarni AD
    Arch Ophthalmol; 2008 May; 126(5):626-31. PubMed ID: 18474771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iris-color change developed after topical isopropyl unoprostone treatment.
    Yamamoto T; Kitazawa Y
    J Glaucoma; 1997 Dec; 6(6):430-2. PubMed ID: 9407373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension.
    Alm A; Grunden JW; Kwok KK
    J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
    Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
    Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.